MAP2K2 and hepatocellular carcinoma: We inhibited ERK1/2 phosphorylation in PBLD-downregulated HCC cell using U0126, a highly selective inhibitor of both MEK1 and MEK2, and found that enhanced expression of HIF-1a and VEGF induced by PBLD downregulation could be inhibited by U0126.